2025/06/18 更新

お知らせ

 

写真a

マツオカ　ワカト
松岡 若利
MATSUOKA WAKATO
所属
九州大学病院 救命救急センター 助教
医学部 医学科（併任）
職名
助教
プロフィール
小児ICU患者における筋肉量と転帰の関係に関する研究
外部リンク

研究分野

  • ライフサイエンス / 救急医学

学位

  • 博士（医学） （ 2025年2月 九州大学 ）

経歴

  • 九州大学  助教 

学歴

  • 長崎大学   医学部   医学科

    2004年4月 - 2010年3月

研究テーマ・研究キーワード

  • 研究テーマ： PICUにおける小児重篤患者の骨格筋量低下と転帰の関連

    研究キーワード： 小児重篤患者、骨格筋量

    研究期間： 2020年4月 - 2024年4月

  • 研究テーマ： 重症頭部外傷の呼吸管理におけるINTELLiVENT-ASVの有用性の確立

    研究キーワード： 重症頭部外傷、呼吸管理

    研究期間： 2020年4月 - 2024年4月

受賞

  • 第47回日本集中治療医学会学術集会優秀演題

    2020年3月   日本集中治療医学会   演題『CTによる小児の骨格筋量の基準値の作成』

論文

  • 特集 呼吸管理-病態把握と緊急介入に必要な知識と技術- 気道の管理 気管チューブの選択と管理

    松岡 若利

    小児内科   56 ( 10 )   1495 - 1498   2024年10月   （ ISSN:03856305 ）

    　詳細を見る

    出版者・発行元：東京医学社  

    DOI： 10.24479/pm.0000002085

    CiNii Research

  • Skeletal Muscle Mass Assessment in Pediatric Patients: Development of a Normative Equation and Assessment of Factors Associated With a Low Skeletal Muscle Mass in PICU Patients

    Matsuoka, W; Mizuguchi, S; Kaku, N; Higashi, K; Tetsuhara, K; Akahoshi, T; Ohga, S

    PEDIATRIC CRITICAL CARE MEDICINE   25 ( 7 )   621 - 628   2024年7月   （ ISSN:1529-7535 eISSN:1947-3893 ）

    　詳細を見る

    記述言語：英語   出版者・発行元：Pediatric Critical Care Medicine  

    OBJECTIVES: To develop an equation for defining a low skeletal muscle mass (SMM) in children and to investigate risk factors and outcomes associated with low SMM in critically ill pediatric patients. DESIGN: Single-center retrospective pediatric cohorts, 2011-2018. SETTING: Tertiary Emergency and Critical Care Center of Kyushu University Hospital in Japan. PATIENTS: We studied two cohorts of pediatric patients 1-15 years old who underwent abdominal CT at the level of the third lumbar vertebra (L3). First a cohort of trauma patients presented to the emergency department in whom we developed an SMM regression equation. Second, a cohort of patients who had undergone abdominal CT within 3 days of PICU admission. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: The equation for estimating normal SMM used sex, age, and weight. Low SMM was defined as less than 80% of normal. In the 112 patients in the PICU cohort, median (range) age was 68 (13-191) months, and 83 (74.1%) had underlying disease. There was low SMM in 54 patients (48.2%). Regarding associations, using odds ratio (OR) and 95% CI, we found that low dietary intake (OR 4.33 [95% CI, 1.37-13.70]; p = 0.013) and the presence of underlying disease (OR 7.44 [95% CI, 2.10-26.30]; p = 0.002) were independently associated with greater odds of low SMM. Low SMM, compared with normal SMM, was also associated with longer hospital stays (42.5 d vs. 20.5 d; p = 0.007; β, 1.59; 95% CI, 1.09-2.33; p = 0.016). CONCLUSIONS: In this retrospective PICU cohort from a single center in Japan, we found that low SMM at PICU admission was present in almost half the cases. Low SMM, as defined by being less than 80% of the normal, was associated with greater odds of low dietary intake and underlying chronic disease. Furthermore, low SMM was associated with longer hospital stays.

    DOI： 10.1097/PCC.0000000000003511

    Web of Science

    Scopus

    PubMed

  • Rapid and long-lasting efficacy of high-dose ambroxol therapy for neuronopathic Gaucher disease: A case report and literature review

    Higashi, K; Sonoda, Y; Kaku, N; Fujii, F; Yamashita, F; Lee, S; Tocan, V; Ebihara, G; Matsuoka, W; Tetsuhara, K; Sonoda, M; Chong, PF; Mushimoto, Y; Kojima-Ishii, K; Ishimura, M; Koga, Y; Fukuta, A; Tsuchihashi, NA; Kikuchi, Y; Karashima, T; Sawada, T; Hotta, T; Yoshimitsu, M; Terazono, H; Tajiri, T; Nakagawa, T; Sakai, Y; Nakamura, K; Ohga, S

    MOLECULAR GENETICS & GENOMIC MEDICINE   12 ( 4 )   e2427   2024年4月   （ ISSN:2324-9269 ）

    　詳細を見る

    記述言語：英語   出版者・発行元：Molecular Genetics and Genomic Medicine  

    Gaucher disease (GD) is a lysosomal storage disorder caused by a deficiency in the GBA1-encoded enzyme, β-glucocerebrosidase. Enzyme replacement therapy is ineffective for neuronopathic Gaucher disease (nGD). High-dose ambroxol has been administered as an alternative treatment for a group of patients with nGD. However, little is known about the clinical indication and the long-term outcome of patients after ambroxol therapy. We herein report a case of a female patient who presented with a progressive disease of GD type 2 from 11 months of age and had the pathogenic variants of p.L483P (formerly defined as p.L444P) and p.R502H (p.R463H) in GBA1. A combined treatment of imiglucerase with ambroxol started improving the patient's motor activity in 1 week, while it kept the long-lasting effect of preventing the deteriorating phenotype for 30 months. A literature review identified 40 patients with nGD, who had received high-dose ambroxol therapy. More than 65% of these patients favorably responded to the molecular chaperone therapy, irrespective of p.L483P homozygous, heterozygous or the other genotypes. These results highlight the long-lasting effect of ambroxol-based chaperone therapy for patients with an expanding spectrum of mutations in GBA1.

    DOI： 10.1002/mgg3.2427

    Web of Science

    Scopus

    PubMed

  • Pretransplant ribavirin and interferon-α therapy for rhinovirus interstitial pneumonia in a RAG1-deficient infant

    Harada, N; Sonoda, M; Ishimura, M; Eguchi, K; Kinoshita, K; Matsuoka, W; Motomura, Y; Kaku, N; Kawaguchi, N; Takeuchi, T; Ohga, S

    JOURNAL OF INFECTION AND CHEMOTHERAPY   30 ( 4 )   362 - 365   2024年4月   （ ISSN:1341-321X eISSN:1437-7780 ）

    　詳細を見る

    記述言語：英語   出版者・発行元：Journal of Infection and Chemotherapy  

    Severe combined immunodeficiency (SCID) is one of the most serious inborn errors of immunity leading to a fatal infection in early infancy. Allogeneic hematopoietic cell transplantation (HCT) or elective gene therapy prior to infection or live-attenuated vaccination is the current standard of curative treatment. Even in the era of newborn screening for SCID, pretransplant control of severe infection is challenging for SCID. Multiple pathogens are often isolated from immunocompromised patients, and limited information is available regarding antiviral strategies to facilitate curative HCT. We herein present a case of successfully controlled pretransplant pneumonia after ribavirin and interferon-α therapy in an infant with RAG1-deficiency. A four-month-old infant presented with severe interstitial pneumonia due to a co-infection of rhinovirus and Pneumocystis jirovecii. The tentative diagnosis of SCID prompted to start antibiotics and trimethoprim-sulfamethoxazole on ventilatory support. Because of the progressive respiratory failure four days after treatment, ribavirin and then pegylated interferon-α were started. He showed a drastic response to the treatment that led to a curative HCT 32 days after admission. This patient received the genetic diagnosis of RAG1-deficiency. Currently, he is an active 3-year-old boy with normal growth and development. The review of literature indicated that rhinovirus had a comparable or rather greater impact on the mortality of pediatric patients than respiratory syncytial virus. Considered the turn-around time to the genetic diagnosis of SCID, prompt ribavirin plus interferon-α therapy may help to control severe rhinovirus pneumonia and led to the early curative HCT for the affected infants.

    DOI： 10.1016/j.jiac.2023.11.003

    Web of Science

    Scopus

    PubMed

  • Pretransplant ribavirin and interferon-α therapy for rhinovirus interstitial pneumonia in a RAG1-deficient infant(タイトル和訳中)

    Harada Nobutaka, Sonoda Motoshi, Ishimura Masataka, Eguchi Katsuhide, Kinoshita Keishiro, Matsuoka Wakato, Motomura Yoshitomo, Kaku Noriyuki, Kawaguchi Naoki, Takeuchi Takami, Ohga Shouichi

    Journal of Infection and Chemotherapy   30 ( 4 )   362 - 365   2024年4月   （ ISSN:1341-321X ）

    　詳細を見る

    記述言語：英語   出版者・発行元：エルゼビア・ジャパン(株)  

    症例は生後4ヵ月の乳児で、ライノウイルスとPneumocystis jiroveciiの共感染による重症間質性肺炎で入院した。暫定的に重症複合免疫不全症と診断し、呼吸補助療法に加えて抗生物質およびスルファメトキサゾール・トリメトプリムを投与した。治療4日後に呼吸不全が進行したため、リバビリンおよびペグインターフェロン-αの投与を開始した。治療に良く反応し、入院32日後に血縁者からの造血幹細胞移植(骨髄移植)を受け、入院120日後に退院した。遺伝子検査によりRAG1欠損症と確定診断された。患者は現在3歳で、成長・発達は正常である。

  • High-Titer Anti-ZSCAN1 Antibodies in a Toddler Clinically Diagnosed with Apparent Rapid-Onset Obesity with Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation Syndrome

    Tocan, V; Nakamura-Utsunomiya, A; Sonoda, Y; Matsuoka, W; Mizuguchi, S; Muto, Y; Hijioka, T; Nogami, M; Sasaoka, D; Nagamatsu, F; Oba, U; Kawakubo, N; Hamada, H; Mushimoto, Y; Chong, PF; Kaku, N; Koga, Y; Sakai, Y; Oda, Y; Tajiri, T; Ohga, S

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES   25 ( 5 )   2024年3月   （ ISSN:1661-6596 eISSN:1422-0067 ）

    　詳細を見る

    記述言語：英語   出版者・発行元：International Journal of Molecular Sciences  

    Severe obesity in young children prompts for a differential diagnosis that includes syndromic conditions. Rapid-Onset Obesity with Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation (ROHHAD) syndrome is a potentially fatal disorder characterized by rapid-onset obesity associated with hypoventilation, neural crest tumors, and endocrine and behavioral abnormalities. The etiology of ROHHAD syndrome remains to be established, but recent research has been focusing on autoimmunity. We report on a 2-year-old girl with rapid-onset obesity during the first year of life who progressed to hypoventilation and encephalitis in less than four months since the start of accelerated weight gain. The patient had a high titer of anti-ZSCAN1 antibodies (348; reference range < 40), and the increased values did not decline after acute phase treatment. Other encephalitis-related antibodies, such as the anti-NDMA antibody, were not detected. The rapid progression from obesity onset to central hypoventilation with encephalitis warns about the severe consequences of early-onset ROHHAD syndrome. These data indicate that serial measurements of anti-ZSCAN1 antibodies might be useful for the diagnosis and estimation of disease severity. Further research is needed to determine whether it can predict the clinical course of ROHHAD syndrome and whether there is any difference in antibody production between patients with and without tumors.

    DOI： 10.3390/ijms25052820

    Web of Science

    Scopus

    PubMed

  • Persistent intracranial hyper-inflammation in ruptured cerebral aneurysm after COVID-19: case report and review of the literature

    Chong, PF; Higashi, K; Matsuoka, W; Arimura, K; Sangatsuda, Y; Iwaki, K; Sonoda, Y; Ichimiya, Y; Kamori, A; Kawakami, A; Mizuguchi, S; Kaku, N; Sakai, Y; Ohga, S

    BMC NEUROLOGY   24 ( 1 )   17   2024年1月   （ eISSN:1471-2377 ）

    　詳細を見る

    記述言語：英語   出版者・発行元：BMC Neurology  

    Background: The systemic manifestations of coronavirus disease 2019 (COVID-19) include hyperinflammatory reactions in various organs. Recent studies showed evidence for the frequent involvement of central nervous system in affected patients; however, little is known about clinical features of cerebrovascular diseases in childhood-onset COVID-19. Case presentation: A 10-year-old boy recovered from SARS-CoV-2 infection without complication. On 14 days after infection, he presented with loss of consciousness. A head computed tomography detected a ruptured cerebral aneurysm at the left posterior cerebral artery accompanying subarachnoid hemorrhage (SAH). Immediate surgical intervention did not rescue the patient, resulting in the demise 7 days after admission. Serological and genetic tests excluded the diagnosis of vasculitis and connective tissue disorders. Retrospective analysis showed markedly higher levels of interleukin (IL)-1β, IL-6 and IL-8 in the cerebrospinal fluid than the serum sample concurrently obtained. A review of literature indicated that adult patients with COVID-19 have a risk for the later development of SAH during the convalescent phase of COVID-19. Conclusions: SAH is a severe complication of COVID-19 in children and adults who have asymptomatic cerebrovascular aneurysms. The markedly high levels of cytokines detected in the cerebrospinal fluid suggested that intracranial hyperinflammatory condition might be one of the possible mechanisms involved in the rupture of a preexisting cerebrovascular aneurysms.

    DOI： 10.1186/s12883-023-03493-z

    Web of Science

    Scopus

    PubMed

  • Survival trends of extracorporeal membrane oxygenation support for pediatric emergency patients in regional and metropolitan areas in Japan

    Kaku N., Matsuoka W., Ide K., Totoki T., Hirai K., Mizuguchi S., Higashi K., Tetsuhara K., Nagata H., Nakagawa S., Kakihana Y., Shiose A., Ohga S.

    Pediatrics and Neonatology   66 ( 1 )   55 - 59   2024年   （ ISSN:18759572 eISSN:2212-1692 ）

    　詳細を見る

    記述言語：英語   出版者・発行元：Pediatrics and Neonatology  

    Background: To assess the performance of pediatric extracorporeal membrane oxygenation (ECMO) centers, outcomes were compared between metropolitan and other areas. Methods: A retrospective cohort study was conducted at three regional centers on Kyushu Island and the largest center in the Tokyo metropolitan area of Japan. The clinical outcomes of patients of ≤15 years of age who received ECMO during 2010–2019 were investigated, targeting the survival and performance at discharge from intensive care units (ICUs), using medical charts. Results: One hundred and fifty-five patients were analyzed (regional, n = 70; metropolitan, n = 85). Survival rates at ICU discharge were similar between the two areas (64%). In regional centers, deterioration of Pediatric Cerebral Performance Category (PCPC) scores were more frequent (65.7% vs. 49.4%; p = 0.042), but survival rates and ΔPCPC scores (PCPC at ICU discharge–PCPC before admission) improved in the second half of the study period (p = 0.005 and p = 0.046, respectively). Veno-arterial ECMO (odds ratio [OR], 3.00; p < 0.03), extracorporeal cardiopulmonary resuscitation (OR, 8.98; p < 0.01), and absence of myocarditis (OR, 5.47; p < 0.01) were independent risk factors for deterioration of the PCPC score. A sub-analysis of patients with acute myocarditis (n = 51), the main indicator for ECMO, revealed a significantly higher proportion of cases with deteriorated PCPC scores in regional centers (51.9% vs. 25.0%; p = 0.049). Conclusions: The survival rates of pediatric patients supported by ECMO in regional centers were similar to those in a metropolitan center. However, neurological outcomes must be improved, particularly in patients with acute myocarditis.

    DOI： 10.1016/j.pedneo.2024.04.005

    Web of Science

    Scopus

    PubMed

  • Critical vitamin deficiencies in autism spectrum disorder: Reversible and irreversible outcomes

    Chong, PF; Torio, M; Fujii, F; Hirata, Y; Matsuoka, W; Sonoda, Y; Ichimiya, Y; Yada, Y; Kaku, N; Ishimura, M; Sasazuki, M; Koga, Y; Sanefuji, M; Sakai, Y; Ohga, S

    EUROPEAN JOURNAL OF CLINICAL NUTRITION   76 ( 11 )   1618 - 1621   2022年11月   （ ISSN:0954-3007 eISSN:1476-5640 ）

    　詳細を見る

    記述言語：英語   出版者・発行元：European Journal of Clinical Nutrition  

    Vitamin deficiencies are an emerging concern in the management of children with autism spectrum disorder (ASD). Particular attention is required for recognizing the variable signs caused by unbalanced food intakes. We herein report two patients with multiple vitamin deficiencies who needed critical care showing different prognoses. Patient 1 with ‘Shoshin’ beriberi presenting with cardiac arrest had thiamine deficiency developed severe neurological sequelae despite rapid vitamin supplementation. Patient 2, who had leg pain and a limping gait, showed a rapid recovery with intravenous infusion and tube feeding after being diagnosed with scurvy. A literature search revealed several children with ASD with critically ill thiamine deficiency, but few reports documented a life-threatening condition in the form of cardiac arrest at the onset. Considering the high observation rate of food selectivity in children with ASD, early intervention is required to prevent the exacerbation of vitamin deficiencies to severe neurological disabilities.

    DOI： 10.1038/s41430-022-01170-x

    Web of Science

    Scopus

    PubMed

  • Ultrasound-guided double central venous access for azygos vein via the ninth and tenth intercostal veins 査読

    Koichiro Yoshimaru, Toshiharu Matsuura, Yasuyuki Uchida, Keisuke Kajihara, Yukihiro Toriigahara, Yuki Kawano, Takuya Kondo, Yoshiaki Takahashi, Wakato Matsuoka, Noriyuki Kaku, Jun Maki, Tomoaki Taguchi

    Journal of Vascular Access   2020年

    　詳細を見る

    記述言語：英語   掲載種別：研究論文（学術雑誌）  

    Some patients with intestinal failure, who are dependent on total parenteral nutrition for long periods, suffer from a lack of suitable conventional venous access points, including axillary, external jugular, internal jugular, subclavian, saphenous, and the brachio-cephalic and femoral veins, due to their occlusion. Furthermore, extensive central venous stenosis and/or thrombosis of the superior and inferior vena cava may preclude further catheterization, so uncommon routes must be used, which can be challenging. In such patients, the azygos vein via the intercostal vein is a viable candidate. Thoracotomy-assisted, thoracoscopy-assisted, and cut-down procedures are currently suggested such access. We found that ultrasound-guided percutaneous puncture method was a safe and minimally invasive approach and successfully placed two central venous lines in preparation for small bowel transplantation via two different intercostal veins (ninth and tenth). Although the lung was actually located just below the target veins, an ultrasound provided augmented and clear vision, which contributed to the safe performance of the procedure without the need for invasive surgical intervention, such as thoracotomy, thoracoscopy, or rib resection using the cut-down technique. Furthermore, constant positive-pressure ventilation during vein puncture under general anesthesia also helps avoid venous collapse. Despite carrying a slight risk of light injury to the lung, artery, and nerve along with the vein compared to other procedures, we believe that ultrasound-guided puncture under general anesthesia is feasible as a minimally invasive method.

    DOI： 10.1177/1129729820937133

  • The Occurrence and Risk Factors of Inappropriately Deep Tip Position of Microcuff Pediatric Endotracheal Tube During PICU Stay: A Retrospective Cohort Pilot Study. 査読 国際誌

    Matsuoka W, Ide K, Matsudo T, Kobayashi T, Nishimura N, Nakagawa S.

    Pediatr Crit Care Med.   2019年11月

    　詳細を見る

    記述言語：日本語   掲載種別：研究論文（学術雑誌）  

  • Transient dysautonomia in an acute phase of encephalopathy with biphasic seizures and late reduced diffusion 査読

    Yuko Ichimiya, Noriyuki Kaku, Yasunari Sakai, Fumiya Yamashita, Wakato Matsuoka, Mamoru Muraoka, Satoshi Akamine, Soichi Mizuguchi, Michiko Torio, Yoshitomo Motomura, Yuichiro Hirata, Yoshito Ishizaki, Masafumi Sanefuji, Hiroyuki Torisu, Hidetoshi Takada, Yoshihiko Maehara, Shouichi Ohga

    Brain and Development   39 ( 7 )   621 - 624   2017年8月

    　詳細を見る

    記述言語：英語   掲載種別：研究論文（学術雑誌）  

    Paroxysmal sympathetic hyperactivity (PSH) is a dysautonomic condition that is associated with various types of acquired brain injuries. Traumatic brain lesions have been documented as the leading cause of PSH. However, detailed clinical features of pediatric PSH caused by intrinsic brain lesions remain to be elusive. We present a 3-year-old boy, who had been diagnosed as having cerebral palsy, developmental delay and epilepsy after perinatal hypoxia-induced brain injury. He developed status epilepticus with fever on the third day of respiratory infection. Whereas the seizure was terminated by systemic infusion of midazolam, consciousness remained disturbed for the next 48 h. Serial magnetic resonance imaging studies revealed that acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) evolved on 3 days after the seizure. Therapeutic hypothermia was immediately introduced, however, the brain lesion extended to the whole subcortical white matters on day 8. The intermittent bilateral dilation of pupils with increased blood pressure and tachycardia were observed until day 12. Real-time monitoring of electroencephalograms ruled out the recurrent attacks of seizures. The abnormal signs of autonomic nervous system gradually ceased and never relapsed after recovery from the hypothermia. PSH or a transient condition of dysautonomia may emerge and persist during the acute phase of AESD.

    DOI： 10.1016/j.braindev.2017.03.023

▼全件表示

講演・口頭発表等

▼全件表示

MISC

所属学協会

  • 日本国際保健医療学会

  • 日本国際小児保健医療学会

  • 日本呼吸療法医学会

  • 日本救急医学会

  • 日本集中治療学会

  • 日本小児科学会

▼全件表示

共同研究・競争的資金等の研究課題

  • 重篤小児患者のリハビリテーションにおける神経筋電気刺激の有効性に関する研究

    研究課題/領域番号：25K14454  2025年4月 - 2028年3月

    科学研究費助成事業  基盤研究(C)

    松岡 若利

    　 詳細を見る

    資金種別：科研費

    CiNii Research

  • 小児ECMO症例の救命のための教育・搬送・集約モデルの開発

    研究課題/領域番号：24K13391  2024年4月 - 2027年3月

    科学研究費助成事業  基盤研究(C)

    賀来 典之, 赤星 朋比古, 水口 壮一, 松岡 若利, 鉄原 健一

    　 詳細を見る

    資金種別：科研費

    本研究は、小児のECMOの施行状況や重篤小児救急患者の調査をもとに、ECMOが必要な
    小児の搬送・受け入れ体制の基盤策定を目的としている。
    国内の小児のECMO施行状況調査、施設調査からECMOの施行状況や需要について検討することに加え、遠隔シミュレーション教育の手法を用いた教育（小児の患者評価・搬送に関する遠隔教育）を行うことで、より実効性のある、連絡・搬送・受け入れ体制の構築を行う。

    CiNii Research

  • 重症頭部外傷の呼吸管理におけるINTELLiVENT-ASVの有用性の確立

    2021年5月

    　 詳細を見る

    担当区分：研究代表者 

  • 重篤小児患者の筋力低下の実態とリスク因子の解明

    研究課題/領域番号：21K11215  2021年 - 2023年

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    松岡 若利, 賀来 典之, 赤星 朋比古, 鉄原 健一

    　 詳細を見る

    担当区分：研究代表者  資金種別：科研費

    小児の集中治療後に持続する運動機能障害は、小児の集中治療後症候群（PICS-p：postintensive care syndrome - pediatrics）の重要な要素である。しかし、PICS-pの実態は十分には把握されておらず、従ってリハビリテーションの効果も定まっていない。本研究は、重篤小児患者における小児集中治療室（PICU：pediatric intensive care unit）入室後の運動機能障害の実態とそのリスク因子の把握を行うことを第一とする。その上でリハビリテーションが重篤小児患者において身体的な長期機能予後の改善に結びつくかどうかを検討する。

    CiNii Research

  • 看護師対象小児急変対応ABCアプローチによる遠隔シミュレーション教育法開発

    研究課題/領域番号：20K10832  2020年4月 - 2023年3月

    科学研究費助成事業  基盤研究(C)

    賀来 典之, 赤星 朋比古, 鉄原 健一, 松岡 若利

    　 詳細を見る

    資金種別：科研費

    小児の院内急変事例では、実際には医師よりも看護師が最初に対応する場合が多い。
    本研究では、シミュレーションを用いた、看護師への小児救急・急変症例への対応実習を、直接指導群とインターネットを介したテレビ電話システムによる遠隔指導群に対して行い、両群での教育効果の比較・検討する。
    小児の評価は、ABCDEアプローチ（A気道、B呼吸、C循環、D神経、E外表観察）によって行い、SBARを用いた報告を行う。
    遠隔指導群・直接指導群ともに、6 か月のシミュレーション実習の前後でビデオ撮影下での実習テストを行い、診療の各要素の検証を行った後、遠隔シミュレーションプログラムの汎用化のための方策を明らかにする。

    CiNii Research

教育活動概要

  • 小児科専攻研修医への臨床指導

大学全体における各種委員・役職等